Jiří Drahota

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection

Dominika Šťastná, Ingrid Menkyová, Jiří Drahota et al. · Multiple Sclerosis and Related Disorders · 2022 · 37 citations · Full text

Vaccination, Vaccine Safety, Preventive Medicine +11

Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia

Dominika Šťastná, Ingrid Menkyová, Jiří Drahota et al. · Multiple Sclerosis and Related Disorders · 2021 · 31 citations · Full text

Specificity of anti‐saliva immune response in mice repeatedly bitten by <i>Phlebotomus sergenti</i>

Jiří Drahota, Marie Lipoldová, Petr Volf et al. · Parasite Immunology · 2009 · 21 citations

Humoral Response, Immunology, Innate Immune System +17

Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

Tereza Hrnčiarová, Jiří Drahota, Tim Spelman et al. · Multiple Sclerosis and Related Disorders · 2023 · 19 citations

Relapsing-remitting Multiple Sclerosis, Neurological Disorder, Clinical Trials +4

The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021

Dominika Šťastná, Jiří Drahota, Michal Lauer et al. · Biomedical Papers · 2023 · 16 citations · Full text